Compare KVUE & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KVUE | ROL |
|---|---|---|
| Founded | 2022 | 1948 |
| Country | United States | United States |
| Employees | 22000 | N/A |
| Industry | Specialty Chemicals | Diversified Commercial Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9B | 26.5B |
| IPO Year | 2023 | 1994 |
| Metric | KVUE | ROL |
|---|---|---|
| Price | $17.10 | $53.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | $19.45 | ★ $64.73 |
| AVG Volume (30 Days) | ★ 16.9M | 2.5M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.82% | 1.32% |
| EPS Growth | ★ 40.74 | 13.54 |
| EPS | ★ 0.25 | 0.22 |
| Revenue | ★ $15,124,000,000.00 | $2,161,220,000.00 |
| Revenue This Year | $4.85 | $10.42 |
| Revenue Next Year | $2.63 | $8.86 |
| P/E Ratio | ★ $68.66 | $242.64 |
| Revenue Growth | N/A | ★ 7.23 |
| 52 Week Low | $14.02 | $51.95 |
| 52 Week High | $24.36 | $66.14 |
| Indicator | KVUE | ROL |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 41.81 |
| Support Level | $16.87 | $52.32 |
| Resistance Level | $17.32 | $59.06 |
| Average True Range (ATR) | 0.37 | 1.07 |
| MACD | -0.03 | -0.15 |
| Stochastic Oscillator | 13.11 | 33.22 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.